Insider Transactions in Q3 2024 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2024
|
Lu Hongbo Director |
BUY
Open market or private purchase
|
Indirect |
476,190
+43.75%
|
$4,761,900
$10.5 P/Share
|
|
Sep 10
2024
|
Mark J. Vignola Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.81%
|
$110,000
$11.0 P/Share
|
|
Sep 10
2024
|
Mark J. Vignola Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.93%
|
$50,000
$5.36 P/Share
|
|
Sep 09
2024
|
Jill M. Quigley |
SELL
Open market or private sale
|
Direct |
17,235
-53.47%
|
$172,350
$10.0 P/Share
|
|
Sep 09
2024
|
Jill M. Quigley |
BUY
Exercise of conversion of derivative security
|
Direct |
17,235
+34.84%
|
$17,235
$1.82 P/Share
|
|
Aug 02
2024
|
Jill M. Quigley |
SELL
Open market or private sale
|
Direct |
8,857
-37.13%
|
$61,999
$7.5 P/Share
|
|
Aug 01
2024
|
Jill M. Quigley |
SELL
Open market or private sale
|
Direct |
6,143
-20.48%
|
$43,001
$7.68 P/Share
|
|
Jul 16
2024
|
Carl L Gordon Director |
SELL
Open market or private sale
|
Indirect |
5,188
-0.06%
|
$51,880
$10.0 P/Share
|
|
Jul 16
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
5,188
-0.06%
|
$51,880
$10.0 P/Share
|
|
Jul 16
2024
|
Jill M. Quigley |
SELL
Open market or private sale
|
Direct |
400
-1.32%
|
$4,000
$10.0 P/Share
|
|
Jul 16
2024
|
Jill M. Quigley |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.3%
|
$400
$1.82 P/Share
|
|
Jul 15
2024
|
Carl L Gordon Director |
SELL
Open market or private sale
|
Indirect |
50,976
-0.63%
|
$509,760
$10.0 P/Share
|
|
Jul 15
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
50,976
-0.63%
|
$509,760
$10.0 P/Share
|
|
Jul 15
2024
|
Jill M. Quigley |
SELL
Open market or private sale
|
Direct |
14,365
-32.38%
|
$143,650
$10.0 P/Share
|
|
Jul 15
2024
|
Jill M. Quigley |
BUY
Exercise of conversion of derivative security
|
Direct |
14,365
+24.46%
|
$14,365
$1.82 P/Share
|